201 related articles for article (PubMed ID: 28704564)
1. Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study.
Ruscitti P; Ursini F; Cipriani P; Liakouli V; Carubbi F; Berardicurti O; De Sarro G; Giacomelli R
PLoS One; 2017; 12(7):e0181203. PubMed ID: 28704564
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study.
Ruscitti P; Ursini F; Cipriani P; Ciccia F; Liakouli V; Carubbi F; Guggino G; Berardicurti O; Grembiale R; Triolo G; De Sarro G; Giacomelli R
Medicine (Baltimore); 2017 Aug; 96(34):e7896. PubMed ID: 28834907
[TBL] [Abstract][Full Text] [Related]
3. Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial.
Ruscitti P; Masedu F; Alvaro S; Airò P; Battafarano N; Cantarini L; Cantatore FP; Carlino G; D'Abrosca V; Frassi M; Frediani B; Iacono D; Liakouli V; Maggio R; Mulè R; Pantano I; Prevete I; Sinigaglia L; Valenti M; Viapiana O; Cipriani P; Giacomelli R
PLoS Med; 2019 Sep; 16(9):e1002901. PubMed ID: 31513665
[TBL] [Abstract][Full Text] [Related]
4. The effects of suppressing inflammation by tofacitinib may simultaneously improve glycaemic parameters and inflammatory markers in rheumatoid arthritis patients with comorbid type 2 diabetes: a proof-of-concept, open, prospective, clinical study.
Di Muzio C; Di Cola I; Shariat Panahi A; Ursini F; Iagnocco A; Giacomelli R; Cipriani P; Ruscitti P
Arthritis Res Ther; 2024 Jan; 26(1):14. PubMed ID: 38178250
[TBL] [Abstract][Full Text] [Related]
5. Patients with newly diagnosed rheumatoid arthritis are at increased risk of diabetes mellitus: an observational cohort study.
Emamifar A; Levin K; Jensen Hansen IM
Acta Reumatol Port; 2017; 42(4):310-317. PubMed ID: 29017177
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study.
Ruscitti P; Cipriani P; Liakouli V; Iacono D; Pantano I; Margiotta DPE; Navarini L; Destro Castaniti GM; Maruotti N; Di Scala G; Caso F; Bongiovanni S; Grembiale RD; Atzeni F; Scarpa R; Perosa F; Emmi G; Cantatore FP; Guggino G; Afeltra A; Ciccia F; Giacomelli R
Clin Exp Rheumatol; 2021; 39(5):995-1002. PubMed ID: 33337994
[TBL] [Abstract][Full Text] [Related]
7. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study.
Lee YC; Cui J; Lu B; Frits ML; Iannaccone CK; Shadick NA; Weinblatt ME; Solomon DH
Arthritis Res Ther; 2011 Jun; 13(3):R83. PubMed ID: 21651807
[TBL] [Abstract][Full Text] [Related]
8. High Proportion of Subjective Component to the Disease Activity Score is Associated with Favorable Response to Abatacept in Rheumatoid Arthritis.
Lee JS; Ahmad H; Shim SC; Bae SC; Song YW; Lee EY
Patient; 2019 Jun; 12(3):319-326. PubMed ID: 30484084
[TBL] [Abstract][Full Text] [Related]
9. Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial.
Svensson AL; Christensen R; Persson F; Løgstrup BB; Giraldi A; Graugaard C; Fredberg U; Blegvad J; Thygesen T; Hansen IM; Colic A; Bagdat D; Ahlquist P; Jensen HS; Hørslev-Petersen K; Sheetal E; Christensen TG; Svendsen L; Emmertsen H; Ellingsen T
BMJ Open; 2016 Apr; 6(4):e009134. PubMed ID: 27098820
[TBL] [Abstract][Full Text] [Related]
10. Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study.
Ruscitti P; Cipriani P; Masedu F; Romano S; Berardicurti O; Liakouli V; Carubbi F; Di Benedetto P; Alvaro S; Penco M; Valenti M; Giacomelli R
PLoS One; 2017; 12(1):e0170108. PubMed ID: 28103312
[TBL] [Abstract][Full Text] [Related]
11. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.
Wells G; Becker JC; Teng J; Dougados M; Schiff M; Smolen J; Aletaha D; van Riel PL
Ann Rheum Dis; 2009 Jun; 68(6):954-60. PubMed ID: 18490431
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with change in arterial stiffness in patients with rheumatoid arthritis: the JointHeart study.
Linde A; Gerdts E; Fevang BT; Eilertsen RK; Kringeland E; Alsing CL; Midtbø H
Blood Press; 2024 May; 33(1):2353167. PubMed ID: 38824646
[TBL] [Abstract][Full Text] [Related]
13. Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.
Ruscitti P; Margiotta DPE; Macaluso F; Iacono D; D'Onofrio F; Emmi G; Atzeni F; Prete M; Perosa F; Sarzi-Puttini P; Emmi L; Cantatore FP; Triolo G; Afeltra A; Giacomelli R; Valentini G
Medicine (Baltimore); 2017 Oct; 96(42):e8180. PubMed ID: 29049200
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study.
Jamnitski A; Visman IM; Peters MJ; Dijkmans BA; Voskuyl AE; Nurmohamed MT
Ann Rheum Dis; 2010 Nov; 69(11):1929-33. PubMed ID: 20498216
[TBL] [Abstract][Full Text] [Related]
15. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
Vermeer M; Kuper HH; Hoekstra M; Haagsma CJ; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
Arthritis Rheum; 2011 Oct; 63(10):2865-72. PubMed ID: 21647867
[TBL] [Abstract][Full Text] [Related]
16. Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.
Ruscitti P; Cipriani P; Liakouli V; Iacono D; Pantano I; Margiotta DPE; Navarini L; Destro Castaniti GM; Maruotti N; Di Scala G; Picciariello L; Caso F; Bongiovanni S; Grembiale RD; Atzeni F; Scarpa R; Perosa F; Emmi G; Cantatore FP; Guggino G; Afeltra A; Ciccia F; Giacomelli R
Arthritis Res Ther; 2019 Sep; 21(1):204. PubMed ID: 31481105
[TBL] [Abstract][Full Text] [Related]
17. Contribution of subjective Disease Activity Score 28 (DAS28) components to the response to treatment of rheumatoid arthritis.
Son KM; Lee SY; Seo YI; Choi JE; Kim HA
Clin Rheumatol; 2017 Jun; 36(6):1221-1227. PubMed ID: 28451869
[TBL] [Abstract][Full Text] [Related]
18. Association between rheumatoid arthritis disease activity, progression of functional limitation and long-term risk of orthopaedic surgery: combined analysis of two prospective cohorts supports EULAR treat to target DAS thresholds.
Nikiphorou E; Norton S; Young A; Carpenter L; Dixey J; Walsh DA; Kiely P;
Ann Rheum Dis; 2016 Dec; 75(12):2080-2086. PubMed ID: 26979104
[TBL] [Abstract][Full Text] [Related]
19. Radiological patterns of pulmonary involvement may predict treatment response in rheumatoid arthritis: A retrospective study.
Hanaka T; Kido T; Ishimoto H; Oda K; Noguchi S; Nawata A; Nakayamada S; Sakamoto N; Tanaka Y; Yatera K; Mukae H
Respir Investig; 2019 Mar; 57(2):172-182. PubMed ID: 30718103
[TBL] [Abstract][Full Text] [Related]
20. Bilateral evaluation of the hand and wrist in untreated early inflammatory arthritis: a comparative study of ultrasonography and magnetic resonance imaging.
Navalho M; Resende C; Rodrigues AM; Pereira da Silva JA; Fonseca JE; Campos J; Canhão H
J Rheumatol; 2013 Aug; 40(8):1282-92. PubMed ID: 23729806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
